Why Bryan Johnson Says He May Have Taken His Longevity Experiment ‘Too Far’

US tech entrepreneur Bryan Johnson, known for spending millions of dollars on longevity research in an effort to slow ageing and extend human life, has said he is reconsidering the mission that made him globally known. In a post on X on Wednesday, July 30, the 48-year-old said he had been reflecting on whether he had taken his longevity experiment "too far," prompting widespread discussion online.

Johnson has spent years following an intensive health regimen that includes strict supplement routines, extensive medical monitoring, plasma transfusions and other experimental approaches aimed at improving longevity. His latest comments come weeks after he disclosed that he had been diagnosed with Autoimmune Gastritis (AIG), a rare condition with no known cure. What Is Autoimmune Gastritis? The Disease Anti Ageing Millionaire Bryan Johnson Says Is ‘Eating His Stomach’.

Bryan Johnson Says He May Have Gone ‘Too Far’ With Longevity Experiment

Bryan Johnson Questions His Longevity Mission

Johnson shared his thoughts in a post on X, writing: "Been thinking things over and wonder if I've taken this whole longevity thing too far." The post quickly gained attention on social media. While many users encouraged him to continue his research, others suggested he redirect his focus toward other goals.

Johnson has built a global profile through his ambitious anti-ageing project, often documenting his medical tests, strict diet, exercise routines and experimental treatments in an effort to reduce his biological age. What Is Bryan Johnson’s ‘Don’t Die’ Strategy? Is He Really Shutting Down His Anti-Ageing Company Blueprint? Here's What Is Known So Far About the Longevity Enthusiast.

Autoimmune Gastritis Diagnosis

Johnson's latest remarks follow his recent disclosure that he has Autoimmune Gastritis (AIG), a rare autoimmune disease in which the body's immune system mistakenly attacks the lining of the stomach.

Although there is currently no cure for the condition, Johnson previously said he intends to "try and solve it" through continuous medical monitoring and experimental therapies. The diagnosis has added a new dimension to public discussion about his longevity project, which has long drawn both praise and criticism.

In a follow-up post, Johnson said the public reaction to his diagnosis reflected what he believes is a broader discomfort with efforts to challenge ageing and extend human life.

He argued that the response went beyond simple schadenfreude—the pleasure some people derive from another person's misfortune—and highlighted the polarised views surrounding his work.

Despite expressing doubts about the scale of his longevity mission, Johnson has not indicated that he plans to end his research or abandon his long-term goal of understanding the ageing process.

(The above story first appeared on LatestLY on Jul 31, 2026 08:14 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).